Explore FHI 360

Feature

Partnering with the private sector to vaccinate for COVID-19 along work commutes

In Indonesia, an FHI 360-led project was a key partner in a concerted effort to increase COVID-19 vaccination coverage during the surge of the delta variant in the country.

Feature

Essential facts: Mpox

Mpox is a public health emergency. Learn facts about the virus as well as considerations for people living with HIV and recommendations for combating misinformation.

Feature

Readying countries for the next infectious disease outbreak

FHI 360 is improving global health security by helping countries prepare their resources locally, because infectious disease outbreaks are also humanitarian crises.

Feature

In Tunisia, youth boost the national vaccination effort

Through the Ma3an project, FHI 360 rallied hundreds of young people to support Tunisia's vaccination campaign to control COVID-19.

News

Equitable COVID-19 vaccine access is a human right

FHI 360 calls on the international community to accelerate development and manufacture of COVID-19 vaccines and guarantee equitable access for every country.

Feature

Filling support gaps for at-risk youth in Jamaica during pandemic-related school closures

To support at-risk youth in vulnerable communities in Jamaica during the COVID-19 pandemic, the Local Partner Development project helped provide psychosocial services and food and hygiene packages.

Feature

A secondary impact of COVID-19: FHI 360 supports students through pandemic

FHI 360 provides social-emotional learning to support children and youth – as well as their parents, caregivers and school stakeholders – during the COVID-19 pandemic.

News

FHI Clinical provides contract research organization capabilities for COVID-19 clinical trial

FHI Clinical has partnered with Infectious Disease Research Institute (IDRI) to provide contract research organization capabilities for an immunotherapy clinical trial to combat COVID-19.

Feature

FHI 360 delivers uninterrupted tuberculosis care during the COVID-19 pandemic

CAP-TB’s emergency response ensures uninterrupted treatment access for multidrug-resistant tuberculosis patients in China during the COVID-19 pandemic.

News

A message about COVID-19 from Patrick Fine, CEO

COVID-19 has revealed compassion and courage and exposed human frailty and folly. A deadly virus that knows no borders and recognizes no divisions in the family of nations reminds us of our common humanity.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Partnering with the private sector to vaccinate for COVID-19 along work commutes

Essential facts: Mpox

Readying countries for the next infectious disease outbreak

In Tunisia, youth boost the national vaccination effort

Equitable COVID-19 vaccine access is a human right

Filling support gaps for at-risk youth in Jamaica during pandemic-related school closures

A secondary impact of COVID-19: FHI 360 supports students through pandemic

FHI Clinical provides contract research organization capabilities for COVID-19 clinical trial

FHI 360 delivers uninterrupted tuberculosis care during the COVID-19 pandemic

A message about COVID-19 from Patrick Fine, CEO

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Search within these results

13 Results Found